TREATMENT OF ISOLATED INTRACRANIAL PROGRESSION OF LUNG CANCER DURING TREATMENT WITH SYSTEMIC EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS (EGFR-TKIs)
Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are an effective treatment for non-small-cell lung cancer (NSCLC) harbouring EGFR mutations. The development of isolated central nervous system (CNS) metastases is a relevant clinical problem in patients who resp...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
European Medical Journal
2015-05-01
|
| Serier: | European Medical Journal Respiratory |
| Fag: | |
| Online adgang: | https://emj.emg-health.com/wp-content/uploads/sites/2/2018/02/Treatment-of-Isolated-Intracranial-Progression-of-Lung-Cancer-During-Treatment-with-Systemic-Epidermal-Growth-Factor-Receptor-Tyrosine-Kinase-Inhibitors-EGFR-TKIs.pdf |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
